Dean Y. Li - 01 Apr 2025 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/ Kyle Nelson, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
01 Apr 2025
Transactions value $
$0
Form type
4
Filing time
03 Apr 2025, 16:37:52 UTC
Previous filing
29 Jan 2025
Next filing
01 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +2,268 +2.93% $0.000000 79,618 01 Apr 2025 Direct F1
holding RXRX Class A Common Stock 1,422,048 01 Apr 2025 By Dean Li and Ruth Li Revocable Trust
holding RXRX Class A Common Stock 1,269,796 01 Apr 2025 By Dean Y. Li GRAT
holding RXRX Class A Common Stock 421,000 01 Apr 2025 By Dean Y. Li 2021 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.